NDC 25021-119

Cefuroxime sodium

Cefuroxime Sodium

Cefuroxime sodium is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Cefuroxime Sodium.

Product ID25021-119_42302821-15bb-4b2c-9e3d-1f2eabc795d8
NDC25021-119
Product TypeHuman Prescription Drug
Proprietary NameCefuroxime sodium
Generic NameCefuroxime Sodium
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-09-01
Marketing CategoryANDA / ANDA
Application NumberANDA064125
Labeler NameSagent Pharmaceuticals
Substance NameCEFUROXIME SODIUM
Active Ingredient Strength2 g/16mL
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 25021-119-20

25 VIAL in 1 CARTON (25021-119-20) > 16 mL in 1 VIAL
Marketing Start Date2016-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 25021-119-20 [25021011920]

Cefuroxime sodium INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA064125
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-01

Drug Details

Active Ingredients

IngredientStrength
CEFUROXIME SODIUM1.5 g/16mL

OpenFDA Data

SPL SET ID:0a145288-733a-4966-b7ae-dc96eb103d8c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665444
  • 1665449
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]
    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "Cefuroxime sodium" or generic name "Cefuroxime Sodium"

    NDCBrand NameGeneric Name
    25021-118Cefuroxime sodiumCefuroxime sodium
    25021-119Cefuroxime sodiumCefuroxime sodium
    25021-182Cefuroxime sodiumCefuroxime sodium
    25021-183Cefuroxime sodiumCefuroxime sodium

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.